Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary uncovered versus fully-covered metal stents for the management of occluded stent in unresectable distal malignant biliary obstruction.
Tejedor-Tejada J, Alvarez-Alvarez A, Olmos JM, González-Bernal AC, Jimenez-Jurado A, Robles-Gaitero S, Perez-Pariente JM. Tejedor-Tejada J, et al. Among authors: perez pariente jm. Gastroenterol Hepatol. 2024 Nov;47(9):502218. doi: 10.1016/j.gastrohep.2024.502218. Epub 2024 Jun 8. Gastroenterol Hepatol. 2024. PMID: 38857753 English, Spanish.
Double-Blind Multicenter Randomized Clinical Trial Comparing Glucagon vs Placebo in the Resolution of Alimentary Esophageal Impaction.
de Benito Sanz M, Tejedor-Tejada J, Mangas-Sanjuan C, Santa E, Cebrian I, Talegón R, Sánchez-Ocaña R, Pérez-Pariente JM, Pérez-Miranda M, García-Alonso FJ; GLUCAGON study group. de Benito Sanz M, et al. Among authors: perez pariente jm. Am J Gastroenterol. 2024 Jan 1;119(1):87-96. doi: 10.14309/ajg.0000000000002511. Epub 2023 Oct 27. Am J Gastroenterol. 2024. PMID: 37734342 Clinical Trial.
Readmissions due to acute biliary edematous pancreatitis in patients without cholecystectomy.
Barreiro Alonso E, Mancebo Mata A, Varela Trastoy P, Pipa Muñiz M, López Fernández E, Tojo González R, García Espiga M, García López R, Pérez Pariente JM, Román Llorente FJ. Barreiro Alonso E, et al. Among authors: perez pariente jm. Rev Esp Enferm Dig. 2016 Aug;108(8):473-8. doi: 10.17235/reed.2016.4067/2015. Rev Esp Enferm Dig. 2016. PMID: 27444192 Free article.
Obstructive jaundice secondary to a hepatic hydatid cyst.
Villán González A, Pérez Pariente JM, Barreiro Alonso E. Villán González A, et al. Among authors: perez pariente jm. Rev Esp Enferm Dig. 2018 Nov;110(11):741-742. doi: 10.17235/reed.2018.5574/2018. Rev Esp Enferm Dig. 2018. PMID: 30238755 Free article.
High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L. Martínez-Borra J, et al. Among authors: perez pariente jm. Am J Gastroenterol. 2002 Sep;97(9):2350-6. doi: 10.1111/j.1572-0241.2002.05990.x. Am J Gastroenterol. 2002. PMID: 12358255
[Abdominal pain and jaundice].
Villán González A, Rivela Vázquez M, Bernardo Fernández H, Vegas San Martín J, Hernández Luyando L, Pérez-Pariente JM. Villán González A, et al. Among authors: perez pariente jm. Rev Clin Esp. 2002 Mar;202(3):173-4. Rev Clin Esp. 2002. PMID: 11996747 Spanish. No abstract available.
Retreatment and maintenance therapy with infliximab in fistulizing Crohn's disease.
Rodrigo L, Pérez-Pariente JM, Fuentes D, Cadahia V, García-Carbonero A, Niño P, de Francisco R, Tojo R, Moreno M, González-Ballina E. Rodrigo L, et al. Among authors: perez pariente jm. Rev Esp Enferm Dig. 2004 Aug;96(8):548-54; 554-8. doi: 10.4321/s1130-01082004000800004. Rev Esp Enferm Dig. 2004. PMID: 15449986 Free article. Clinical Trial. English, Spanish.